Medically reviewed by Matthew Wosnitzer, MD Key Takeaways An eGFR below 60 ml/min indicates possible kidney disease. High ...
WINSTON-SALEM, N.C., June 10, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD) ...
Blood tests for Alzheimer’s disease are rapidly moving into clinics, promising earlier and easier detection of brain changes ...
Regulus Therapeutics Inc. (NASDAQ:RGLS) released topline results from all patients in the fourth cohort in its Phase 1b MAD study of farabursen (RGLS8429) autosomal dominant polycystic kidney disease ...
Six-month open-label study showed clinically meaningful improvements in kidney function and disease in patients with Type 2 diabetic nephropathy. 71% achieved a >30% reduction in UP/Cr, a key ...
WATERTOWN, Mass., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel ...
That vitamin bottle on your kitchen counter promising improved energy, stronger immunity, or enhanced performance might hide an uncomfortable truth – many popular supplements can damage your kidneys ...
A large study found that people with impaired kidneys tend to have higher Alzheimer’s biomarkers, yet they don’t face a higher overall risk of dementia. For those who already have elevated biomarkers, ...